Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $3,988 - $5,726
64 Added 48.85%
195 $16,000
Q3 2022

Oct 25, 2022

SELL
$59.54 - $68.01 $32,449 - $37,065
-545 Reduced 80.62%
131 $8,000
Q2 2022

Aug 01, 2022

SELL
$57.72 - $65.01 $143,203 - $161,289
-2,481 Reduced 78.59%
676 $42,000
Q4 2021

Jan 31, 2022

SELL
$64.88 - $73.64 $18,555 - $21,061
-286 Reduced 8.31%
3,157 $229,000
Q3 2021

Nov 02, 2021

BUY
$67.69 - $73.03 $215,254 - $232,235
3,180 Added 1209.13%
3,443 $240,000
Q1 2021

May 03, 2021

BUY
$60.0 - $68.46 $15,780 - $18,004
263 New
263 $17,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Qvr LLC Portfolio

Follow Qvr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qvr LLC with notifications on news.